Silicone breast implants not associated with connective-tissue disease -- NEJM study.
This article was originally published in The Gray Sheet
Executive Summary
SILICONE BREAST IMPLANTS: NO INCREASED RISK OF CONNECTIVE-TISSUE DISEASES was found in an analysis of 14 years of follow-up data from the Nurses' Health Cohort study, Jorge Sanchez-Guerrero, MD, Harvard Medical School, Boston, et al. report in a study published in the June 22 New England Journal of Medicine. The researchers say that they "found no evidence of an association between silicone breast implants and either connective-tissue diseases defined according to a variety of standardized criteria or signs or symptoms of connective-tissue disease."
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.